arrow
F

Fabrizio Dal Piaz

University of Salerno
H指数:45
被引数:6,372

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Calcium as a molecular switch that regulates Annexin A11 N- and C-terminal domains interaction and its role in ALS

钙作为分子开关,调控Annexin A11 N端和C端结构域的相互作用及其在ALS中的作用

2026-03-280
OAAI
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer

肿瘤源性LIF促进GDF15驱动的恶病质及胃癌的不良预后

Cells
IF5.2
2026-02-170
OAAI
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg

老年ACS患者接受经皮冠状动脉介入治疗时,Ticagrelor 60 mg与90 mg的性别差异

2025-11-010
OA
Multicomponent-based analyses of ACS-patient-derived extracellular vesicles as likely tools for tailored interventional approaches

基于多组分分析的ACS患者来源外泌体作为定制干预方法的潜在工具

2025-09-080
OAAI
Unravelling a new enzymatic activity of non-specific lipid transfer protein Cor a 8: A novel lipase from hazelnuts

揭示非特异性脂质转移蛋白Cor a 8的一种新的酶活性:一种来自榛子的新型脂肪酶

2025-08-050
OA
Multiomic Profiling and Neuroprotective Bioactivity of Salvia Hairy Root-Derived Extracellular Vesicles in a Cellular Model of Parkinson's Disease

在帕金森氏病的细胞模型中,丹参毛状根衍生的细胞外囊泡的多组谱和神经保护生物活性

2024-09-013
OAAI
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial
2024-07-181
PRE
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

rs822336与C/ebp β 和NFIC的结合调节PD-L1表达的诱导并预测晚期NSCLC的anti-PD-1/PD-L1治疗

2024-03-257
OAAI
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms

rs822336作为晚期NSCLC anti-PD-1/PD-L1免疫治疗的预测性生物标志物: 分子机制

2024-03-220
PRE
Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholamines
2023-10-119
OAAI
Bcl-2 family inhibitors sensitize human cancer models to therapy
2023-07-1713
OAAI